Capricor Therapeutics
CAPR • NASDAQ
Capricor Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Linda Marbán, with a market cap of $1.7B.
CEOLinda Marbán
Next Earnings
Upcoming earnings announcement for Capricor Therapeutics
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.53
Revenue Estimate
$25.2M
Earnings History
Past 12 earnings reports for Capricor Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 12, 2026 | Q4 2025 | -$0.62Est: -$0.53 | -17.0% | -Est: $1.7M | -100.0% | — |
| Nov 10, 2025 | Q3 2025 | -$0.54Est: -$0.54 | 0.0% | -Est: $1.2M | -100.0% |  10-Q |
| Aug 11, 2025 | Q2 2025 | -$0.57Est: -$0.48 | -18.7% | -Est: $1.6M | -100.0% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.53Est: -$0.32 | -65.6% | -Est: $3.2M | -100.0% | 10-Q |
| Mar 19, 2025 | Q4 2024 | -$0.16Est: -$0.31 | +48.4% | $11.1MEst: $3.2M | +247.8% | 10-K |
| Nov 13, 2024 | Q3 2024 | -$0.38Est: -$0.36 | -5.6% | $2.3MEst: $3.6M | -36.6% | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.35Est: -$0.36 | +2.8% | $4.0MEst: $3.7M | +8.5% | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.31Est: -$0.11 | -181.8% | $4.9MEst: $9.7M | -49.4% | 10-Q |
| Feb 29, 2024 | Q4 2023 | -$0.02Est: -$0.09 | +77.8% | $12.1MEst: $10.6M | +14.0% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.25Est: -$0.29 | +13.8% | $6.2MEst: $2.1M | +193.1% | — |
| Aug 7, 2023 | Q2 2023 | -$0.29Est: -$0.35 | +17.1% | $3.9MEst: $1.5M | +161.1% | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.31Est: -$0.32 | +3.1% | $3.0MEst: $500.0K | +497.4% | 10-Q |